Literature DB >> 29546999

Association of angiotensin-converting enzyme gene polymorphism with pulse pressure and its interaction with obesity status in Heilongjiang province.

Ningning Wang1, Xueyan Li1, Qi Zhang1, Hao Zhang1, Li Zhou1, Nan Wu1, Ming Jin1, Changchun Qiu1,2, Keyong Zhang1.   

Abstract

Angiotensin I converting enzyme (ACE) gene is one of the most-studied candidate genes related to essential hypertension (EH). Pulse pressure (PP) may reflect vascular stiffness, especially in patients with EH, and has been used to predict EH. Previous evidence has indicated that obesity is a traditional risk factor of hypertension. The aim of the present study was to investigate the interaction between the obesity status and ACE gene polymorphisms on the development of high level of PP. A total of 1980 adults (1024 hypertensive and 956 normotensive) were included in this study and genotyped for ACE gene polymorphisms. The results showed that rs4343 and rs4351 in ACE gene were risk factors of high level of pulse pressure (p < 0.05). We also detected positive interactions between the two SNPs and obesity status in the pathway of high level PP.

Entities:  

Keywords:  ACE; Single nucleotide polymorphism; hypertension; obesity status; pulse pressure

Mesh:

Substances:

Year:  2018        PMID: 29546999     DOI: 10.1080/10641963.2018.1445749

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  2 in total

1.  Genetic Polymorphism of Angiotensin II Type 1 Receptors and Their Effect on the Clinical Outcome of Captopril Treatment in Arab Iraqi Patients with Acute Coronary Syndrome (Mid Euphrates).

Authors:  Fadhaa A Ghafil; Bassim I Mohammad; Hussain S Al-Janabi; Najah R Hadi; Hayder A Al-Aubaidy
Journal:  Indian J Clin Biochem       Date:  2019-12-02

2.  Association of AGTR1 gene methylation and its genetic variant in Chinese farmer with hypertension: A case-control study.

Authors:  Zhi-Yuan Li; Qiang Ma; Xing Li; Shui-Yuan Yu; Juan Zuo; Chong-Jian Wang; Wen-Jie Li; Yue Ba; Fang-Fang Yu
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.